ROYALTY PHARMA PLC news, videos and press releases - Page 4
For more news please use our advanced search feature.
ROYALTY PHARMA PLC - More news...
ROYALTY PHARMA PLC - More news...
- Royalty Pharma Announces 12% Dividend Increase
- Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 10
- Royalty Pharma to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
- Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
- Royalty Pharma Reports Third Quarter 2021 Results
- Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021
- Royalty Pharma Declares Fourth-Quarter 2021 Dividend
- Royalty Pharma to Present at Upcoming Investor Conferences
- Royalty Pharma Reports Second Quarter 2021 Results
- Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021
- Royalty Pharma Declares Third-Quarter 2021 Dividend
- Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond
- Royalty Pharma to Present at Upcoming Investor Conferences
- Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
- Royalty Pharma Reports First Quarter 2021 Results
- Royalty Pharma to Present at Upcoming Investor Conferences
- Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021
- Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes
- Royalty Pharma Declares Second-Quarter 2021 Dividend
- Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
- Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK
- Royalty Pharma Appoints Henry A. Fernandez as Lead Independent Director
- Royalty Pharma Reports Q4 2020 and Full-Year Results
- Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021
- Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences
- Royalty Pharma Announces 13% Dividend Increase
- Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 12
- Royalty Pharma Announces Charitable Gifts to Support COVID-19 Research at Leading Hospitals and Universities
- Royalty Pharma Announces Expansion of Leadership Team
- Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
